Baihua Pharmaceutical: The company continues to suspend trading as it plans for a change in control.

In the announcement by Baihua Pharmaceuticals, the company's controlling shareholder and actual controller are planning to transfer the company's shares agreement, which may result in a change in the company's ownership. Due to the uncertainty of this matter, the company's stock has been suspended from trading since March 31, 2026, and is expected to be suspended for no more than 3 trading days.